Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autonomous hyperparathyroidism in X-linked hypophosphataemia

J Knudtzon1, J Halse, E Monn

  • 1Department of Endocrinology, Rikshospitalet, Oslo, Norway.

Clinical Endocrinology
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Aluminium metabolism in chronic renat failure: Environmental influences and regional differences in Norway.

Environmental geochemistry and health·2013
Same author

A preliminary study of aluminium in serum and other human materials in subjects from different areas of Norway.

Environmental geochemistry and health·2013
Same author

The new curriculum at the medical faculty.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2010
Same author

Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.

Scandinavian journal of clinical and laboratory investigation·2008
Same author

Vascular relationships in right colectomy for cancer: clinical implications.

Techniques in coloproctology·2007
Same journal

Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH.

Clinical endocrinology·2026
Same journal

Subacute Thyroiditis in Denmark: A Nationwide Study of 1763 Cases.

Clinical endocrinology·2026
Same journal

Pubertal Dynamics of Sertoli and Leydig Cell Dysfunction in Klinefelter Syndrome.

Clinical endocrinology·2026
Same journal

Regarding Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11, and GATA3 Mutations in Parathyroidology.

Clinical endocrinology·2026
Same journal

Dual Metabolic Burden of Polyendocrine Metabolic Ovarian Syndrome (PMOS) and Gestational Diabetes in Pregnancy: Impact on Neonatal Anthropometry: Insights From the Born in Bradford Cohort.

Clinical endocrinology·2026
Same journal

Preoperative CALLY Index for Identifying Atypical Parathyroid Tumors.

Clinical endocrinology·2026
See all related articles

Familial hypophosphataemic rickets can lead to persistent hypercalcaemia and hyperparathyroidism. Evaluate for autonomous hyperparathyroidism during follow-up for these patients.

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Bone Disease

Background:

  • Familial hypophosphataemic rickets (FHR) is a rare genetic disorder affecting phosphate metabolism.
  • Vitamin D therapy is standard, but potential complications require monitoring.

Observation:

  • Four FHR patients developed persistent hypercalcaemia and elevated parathyroid hormone (PTH) levels.
  • These patients underwent surgery for hyperparathyroidism, with some having prior phosphate or calcitriol treatment.

Findings:

  • Histological examination showed parathyroid hyperplasia in all patients.
  • Elevated PTH and/or calcium levels persisted post-surgery, indicating autonomous hyperparathyroidism.

Implications:

  • Autonomous hyperparathyroidism is a potential complication in FHR patients.

Related Experiment Videos

  • Regular monitoring for hypercalcaemia and PTH is crucial for managing FHR.